Phenotypes | MRSA (%) | MSSA (%) | Chi-square statistic | p-value |
|---|
cMLSB (EM-R, CD-R) | 3 (20%) | 4 (17.4%) | 0.05* | 0.822 |
iMLSB (EM-R, CD-S, D +) | 6 (40%) | 8 (34.9%) | 0.11 | 0.745 |
MS (EM-R, CD-S, D−) | 2 (13.3%) | 5 (21.7%) | 0.05* | 0.822 |
Susceptible (EM-S, CD-S) | 4 (26.7%) | 6 (26%) | 0.11* | 0.736 |
Total | 15 (100%) | 23 (100%) | | |
- MRSA methicillin-resistant Sthaphylococcus aureus, MSSA methicillin-susceptible Staphylococcus aureus, MLSB macrolide lincosamide-streptogramin B family of antibiotics, cMLSB constitutive MLSB phenotype, iMLSB inducible MLSB phenotype, MS macrolide-streptogramin B phenotype, EM erythromycin, CD clindamycin, R resistant, S susceptible, D+ D-zone test positive, D− D-zone test negative, *Represent the chi-square value with Yates correction
